Yale University

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

TitlePrognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
Publication TypeJournal Article
Year of Publication2008
AuthorsHarris, Ross J., Jonathan A. C. Sterne, Sophie Abgrall, François Dabis, Peter Reiss, Michael Saag, Andrew N. Phillips, Geneviève Chêne, John M. Gill, Amy C. Justice, Jürgen Rockstroh, Caroline A. Sabin, Amanda Mocroft, Heiner C. Bucher, Robert S. Hogg, Antonella d'Arminio Monforte, Margaret May, and Matthias Egger
Corporate AuthorsAntiretroviral Therapy Cohort Collaboration
JournalAntiviral therapy
Volume13
Issue8
Pagination959-67
Date Published2008
ISSN1359-6535
KeywordsAdult, Anemia, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Cohort Studies, Female, HIV Infections, HIV-1, Humans, Male, Odds Ratio, Prognosis, Prospective Studies
AbstractIn HIV type-1-infected patients starting highly active antiretroviral therapy (HAART), the prognostic value of haemoglobin when starting HAART, and of changes in haemoglobin levels, are not well defined.
DOI10.1111/j.1530-0277.2011.01601.x
Alternate JournalAntivir. Ther. (Lond.)

External Links